Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00KJV
|
|||
| Former ID |
DNC013620
|
|||
| Drug Name |
N-butylgalactonojirimycin
|
|||
| Synonyms |
N-butylgalactonojirimycin; CHEMBL485842
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H21NO5
|
|||
| Canonical SMILES |
CCCCN1C(C(C(C(C1O)O)O)O)CO
|
|||
| InChI |
1S/C10H21NO5/c1-2-3-4-11-6(5-12)7(13)8(14)9(15)10(11)16/h6-10,12-16H,2-5H2,1H3/t6-,7+,8+,9-,10+/m1/s1
|
|||
| InChIKey |
JNYIOZRCMYRRED-KBDSZGMXSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Ceramide glucosyltransferase (UGCG) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Sphingolipid metabolism | |||
| Metabolic pathways | ||||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
| Pathwhiz Pathway | Sphingolipid Metabolism | |||
| Pathway Interaction Database | IL2 signaling events mediated by PI3K | |||
| Reactome | Glycosphingolipid metabolism | |||
| WikiPathways | Sphingolipid metabolism | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis. J Biol Chem. 2007 Nov 9;282(45):32655-64. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.